Recently, the use of mobilizing agents such as granulocyte colony-stimulating factor has renewed interest in these treatment modalities. Some studies have shown a benefit in neutropenic patients ...

Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...

How does G-CSF work? Growth factors are proteins made in the body. Some of them make the bone marrow produce blood cells. G-CSF is a type of growth factor that makes the bone marrow produce more white ...

The growth factor granulocyte-colony-stimulating factor (G-CSF) mobilizes CD34 + stem cells from the bone marrow into peripheral blood, and has shown neuroprotective and regenerative activity in ...

Data from a Cencora study showed some misalignment in payer coverage of granulocyte colony-stimulating factor (G-CSF) ...

Recombinant granulocyte-CSF (G-CSF) and granulocyte–macrophage-CSF (GM-CSF) have now been used to increase dangerously low white blood cell levels in many millions of cancer patients following ...

H ealth Canada has granted approval to Nora Pharma for the commercialisation of its first biosimilar product, Niopeg (a ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system homeostasis. When the immune system malfunctions, irregularities in cytokine ...

The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.

Reported positive data from three-month evaluable CIS patients treated across ongoing TARA-002 clinical program in NMIBCPreliminary data from ...

This inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) is presently in Phase 3 development concerning ...

Kiniksa Pharmaceuticals Ltd.'s (KNSA) flagship product Arcalyst has garnered widespread acclaim and acceptance since its launch in ...